Kuros Biosciences AG (CSBTF)

PNK: CSBTF · Real-Time Price · USD

32.47

0.07 (0.22%)

At close: May 02, 2025, 12:15 PM

Kuros Biosciences Balance Sheet Statement

Financials in CHF. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	17.46M	14.28M	14.21M	16.86M	24.07M	21.56M	28.62M	27.22M	28.39M	15.21M	20.8M	12.62M	18.33M	9.65M	16.67M	21.42M	12.37M	17.45M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	16.51M	50.67M	51.05M	-54K	n/a	-308K	-295K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15K
Other Long-Term Assets	n/a	209K	-16.49M	-50.67M	-51.05M	53K	-4.98M	308K	295K	n/a	-2.04M	n/a	n/a	-1K	n/a	n/a	15K	30K
Receivables	14.93M	9.15M	6.41M	4.16M	2.82M	n/a	1.69M	1.78M	1.04M	522K	759K	631K	214K	71K	154K	553K	308K	134K
Inventory	9.44M	6.85M	4.86M	4.39M	3.17M	2.34M	1.76M	1.38M	1.46M	1.23M	954K	665K	547K	417K	220K	146K	684K	1.00
Other Current Assets	2.92M	1.82M	1.21M	1.02M	801K	534K	356K	399K	2.54M	309K	316K	190K	413K	385K	364K	301K	373K	163K
Total Current Assets	44.75M	33.24M	27.19M	27.09M	31.39M	32.24M	32.89M	31.52M	33.97M	17.75M	23.29M	14.43M	19.83M	10.86M	17.67M	23.72M	13.4M	17.94M
Property-Plant & Equipment	3.02M	2.94M	2.64M	3.21M	2.32M	2.18M	2.45M	2.72M	2.59M	2.76M	2.78M	3.04M	634K	648K	630K	325K	45K	48K
Goodwill & Intangibles	34.42M	40.91M	40.98M	47.46M	48.73M	53.8M	56M	58.95M	57.51M	60.32M	61.78M	63.65M	65.35M	67.47M	67.78M	66.85M	30.31M	30.66M
Total Long-Term Assets	39.78M	44.06M	48.71M	51.17M	51.55M	56.02M	58.44M	61.98M	60.4M	63.08M	64.56M	66.7M	65.99M	68.11M	68.41M	67.17M	30.37M	30.73M
Total Assets	84.54M	77.3M	75.91M	78.26M	82.95M	88.27M	91.34M	93.49M	94.36M	80.83M	87.85M	81.13M	85.82M	78.97M	86.08M	90.89M	43.77M	48.66M
Account Payables	6.91M	2.83M	1.3M	1.19M	1.3M	920K	846K	601K	936K	490K	1.06M	673K	1.61M	911K	1.32M	1.58M	1.27M	1.18M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	104K	n/a	412K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	13.46M	8.73M	3.44M	5.66M	5.91M	8.43M	6.53M	166K	69K	n/a	48K	n/a	n/a	75K	206K	n/a	n/a	n/a
Total Current Liabilities	20.9M	12.16M	13.19M	12.01M	12.59M	13.27M	11.29M	3.74M	3.88M	3.1M	3.64M	3.12M	4.04M	2.96M	4.66M	4.87M	3.27M	2.3M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.3M	3.6M	4.44M	-1K	n/a	n/a	1.24M	2.7M	3.83M	3.46M	4.21M	4.51M	5.3M	7.31M	8.29M	8.38M	2.18M	3.41M
Total Long-Term Liabilities	4.89M	4.96M	6.01M	2.29M	1.5M	1.79M	3.07M	4.8M	5.89M	5.63M	6.36M	6.83M	5.3M	7.31M	8.29M	8.38M	2.18M	3.41M
Total Liabilities	25.79M	17.13M	19.19M	14.29M	14.09M	15.07M	14.36M	8.54M	9.76M	8.72M	10M	9.95M	9.34M	10.27M	12.94M	13.25M	5.45M	5.72M
Total Debt	1.79M	1.96M	5.52M	2.87M	1.91M	1.94M	2.15M	2.4M	2.34M	2.55M	2.39M	2.97M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	3.79M	3.71M	3.68M	3.66M	3.66M	3.28M	3.28M	32.81M	32.81M	22.47M	22.47M	15.2M	15.06M	8.23M	8.17M	7.6M	5.08M	5.08M
Retained Earnings	-45.43M	-42.79M	-42.15M	-121.27M	-116.25M	-105.02M	-101.17M	-93.03M	-93.15M	-88.05M	-81.9M	-75.32M	-69.43M	-62.23M	-57.16M	-49.81M	-43.34M	-37.35M
Comprehensive Income	n/a	n/a	21.89M	21.04M	20.9M	20.21M	20.71M	21.31M	21.02M	20.11M	20.06M	20.4M	18.65M	18.38M	17.97M	17.36M	15.93M	14.52M
Shareholders Equity	58.75M	60.17M	56.71M	63.96M	68.86M	73.2M	76.98M	84.95M	84.6M	72.1M	77.86M	71.18M	76.48M	68.7M	73.14M	77.65M	38.32M	42.95M
Total Investments	n/a	16.17M	16.51M	50.67M	51.05M	-54K	n/a	-308K	-295K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15K	15K